Origin Endoscopy
Englewood, US · Founded 2022 · Delaware corporation · 1 known investors
Origin Endoscopy has developed a multipurpose hydrogel designed for rapid bio-adhesion and submucosal injection applications in endoscopy. The technology targets surgical and medical procedure workflows that require biocompatible materials.
Founders & leadership
JY
Jason YlizardeExecutive
JS
Jeremy StarkweatherExecutive
JW
John WynneExecutive
Board
MF
JG
Jason GrimesBoard director
SH
Stephen HoagBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 1 round · 2024
▶$2.3MraisedJun 2025 · 5 investors · BiotechnologyRule 506(b)
▶$2.3MraisedJun 2025 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael FreemanDirector
- Jason YlizardeExecutive Officer
- Jason GrimesDirector
- Jeremy StarkweatherExecutive Officer, Director
- John WynneExecutive Officer, Director
- Stephen HoagDirector
- Offering amount
- $2.6M
- Amount sold
- $2.3M
- Minimum investment
- $10K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Origin Endoscopy do?
- Origin Endoscopy has developed a multipurpose hydrogel designed for rapid bio-adhesion and submucosal injection applications in endoscopy. The technology targets surgical and medical procedure workflows that require biocompatible materials.
- Who are Origin Endoscopy's investors?
- Origin Endoscopy's investors include Innosphere Ventures.
- How much funding has Origin Endoscopy raised?
- Origin Endoscopy has disclosed $2.3M raised across 1 round.
- Where is Origin Endoscopy headquartered?
- Origin Endoscopy is headquartered in Englewood, US.